First-in-class treatment option reduces number and intensity of hot flashes and night sweatsÂ
TOKYO, Dec. 10, 2023 /PRNewswire/ Astellas Pharma Inc. today announced the European Commission on.
A treatment option to reduce the number and intensity of hot flashes and night sweats associated with menopause has been approved by the European Commission (EC).
Patients with migraine are less likely to respond to the new CGRP monoclonal antibody preventive treatments, if they have certain psychiatric disorders, new research shows.
Global Healthcare Leaders Advance Sector Decarbonisation Ahead Of COP28 pollutiononline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pollutiononline.com Daily Mail and Mail on Sunday newspapers.
In the latest issue of Nature Biotechnology, EuroStemCell scientist Elena Cattaneo from University of Milano along with Mauro Toselli from University of Pavia, Elisabetta Cerbai from the University of Florence and Ferdinando Rossi of University of Torino have challenged findings published in the same journal last year that amniotic fluid-derived st